Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 7, 2007

UCB Wins License from Lonza to GS Gene Expression System

  • Lonza granted UCB a nonexclusive, worldwide license to their GS Gene Expression System™ (GS: glutamine synthetase).

    The research evaluation agreement covers the use of the technology for R&D. An option to obtain a license to use the system for commercial purposes is included in the agreement.

    “We believe that having UCB select the GS Gene Expression System underscores the importance of this technology for the efficient production of therapeutic antibodies and recombinant proteins,” says Karen Fallen, commercial licensing manager at Lonza.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »